pr-inside.com
Print
Nabi Biopharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nabi Biopharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released



companiesandmarkets.com
2009-11-10 00:53:03 - Nabi Biopharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/nabi-biophar ..

Nabi Biopharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Nabi Biopharmaceuticals is a pharmaceutical company engaged in applying vaccine and antibody technologies to develop new products for unmet medical needs. It commercializes its products to dialysis centers, hospitals and physician specialties. The company principally focuses on the areas of nicotine addiction and infectious disease. It is headquartered in Rockville,

 

 

Maryland of the United States. The company did not generate any revenues in the fiscal year ended December 2008. The operating loss of the company was $25.0 million during the fiscal year 2008, as compared to an operating loss of $44.9 million during 2007.

The Nabi Biopharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.